Medicare Enrolled

Dr. Rhoderick Nazario, M.D.

Pulmonary Disease · Kissimmee, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1121 N CENTRAL AVE, Kissimmee, FL 34741
4079331221
In practice since 2006 (19 years)
NPI: 1962466730 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nazario from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nazario? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nazario

Dr. Rhoderick Nazario is a pulmonary disease in Kissimmee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Nazario performed 950 Medicare services across 662 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nazario received a total of $7,653 from 34 pharmaceutical and/or device companies across 360 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nazario is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 950 Medicare services$ $7,653 industry payments

Medicare Practice Summary

Medicare Utilization ↗
950
Medicare services
Bottom 46% in FL for pulmonary disease
662
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)148$92$178
Hospital follow-up visit, high complexity140$95$212
Critical care, first 30-74 min130$159$555
Hospital follow-up visit, moderate complexity112$62$137
Office visit, established patient (20-29 min)105$63$130
Test to measure expiratory airflow and volume changes before and after medication administration59$27$150
Test to examine how well the lungs exchange gases57$43$150
Test to determine lung volumes using sensors56$40$150
Initial hospital admission, high complexity27$135$250
New patient office visit (30-44 min)20$72$182
Test for exercise-induced lung stress18$27$125
New patient office visit (45-59 min)14$119$252
Artery puncture collection of blood sample13$20$69
Blood gases measurement, with o2 saturation13$71$212
Red blood cell concentration measurement13$2$41
Blood count, hemoglobin13$2$41
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation12$60$350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,653
Total received (2018-2024)
Avg $1,093/year across 7 years
Top 27% in FL for pulmonary disease
34
Companies
360
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,636 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$47
2023
$1,599
2022
$1,522
2021
$1,207
2020
$1,273
2019
$1,277
2018
$728

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,610
AstraZeneca Pharmaceuticals LP
$1,285
Boehringer Ingelheim Pharmaceuticals, Inc.
$764
Actelion Pharmaceuticals US, Inc.
$439
Regeneron Healthcare Solutions, Inc.
$371
GENZYME CORPORATION
$358
Insmed, Inc.
$316
Mylan Specialty L.P.
$248
Takeda Pharmaceuticals U.S.A., Inc.
$236
Genentech USA, Inc.
$234
Grifols USA, LLC
$204
Teva Pharmaceuticals USA, Inc.
$186
JAZZ PHARMACEUTICALS INC.
$183
Pulmonx Corporation
$144
Electromed, Inc.
$144
Inspire Medical Systems, Inc.
$123
Harmony Biosciences LLC
$122
Sunovion Pharmaceuticals Inc.
$115
UCB, Inc.
$95
Mallinckrodt Hospital Products Inc.
$94
Novartis Pharmaceuticals Corporation
$69
Gilead Sciences, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$39
Ethicon Inc.
$36
Axsome Therapeutics, Inc.
$25
Allergan Inc.
$24
United Therapeutics Corporation
$24
HARMONY BIOSCIENCES LLC
$23
ANI Pharmaceuticals, Inc.
$23
Inogen, Inc.
$20
Melinta Therapeutics, LLC
$18
Shionogi Inc
$16
Mallinckrodt LLC
$12
Fisher & Paykel Healthcare Inc
$11
Top 3 companies account for 47.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CHARTIS CATHETER · CINQAIR · CUVITRU · DALIRESP · DUPIXENT · Dymista · Esbriet · FARXIGA · FASENRA · Fetroja · GLASSIA · InogenOne · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · MONARCH · NUCALA · Neupro · OFEV · OPSUMIT · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Utibron · Veklury · WAKIX · Wakix · XOLAIR · XYREM · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $806 per 100 Medicare services performed
Looking for a pulmonary disease in Kissimmee?
Compare pulmonary diseases in the Kissimmee area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
45
Per 100K population
11.1
County median income
$68,711
Nearest hospital
HCA FLORIDA OSCEOLA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nazario is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nazario experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nazario performed 148 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nazario receive payments from pharmaceutical companies?
Yes. Dr. Nazario received a total of $7,653 from 34 companies across 360 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nazario's costs compare to other pulmonary diseases in Kissimmee?
Dr. Nazario's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nazario) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →